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Abstract
Pneumonia caused by Rhodococcus equi is a common cause of disease and death in foals. Although agent and
environmental factors contribute to the incidence of this disease, the genetic factors influencing the clinical outcomes of R.
equi pneumonia are ill-defined. Here, we performed independent single nucleotide polymorphism (SNP)- and copy number
variant (CNV)-based genome-wide association studies to identify genomic loci associated with R. equi pneumonia in foals.
Foals at a large Quarter Horse breeding farm were categorized into 3 groups: 1) foals with R. equi pneumonia (clinical group
[N = 43]); 2) foals with ultrasonographic evidence of pulmonary lesions that never developed clinical signs of pneumonia
(subclinical group [N= 156]); and, 3) foals without clinical signs or ultrasonographic evidence of pneumonia (unaffected
group [N = 49]). From each group, 24 foals were randomly selected and used for independent SNP- and CNV-based genome-
wide association studies (GWAS). The SNP-based GWAS identified a region on chromosome 26 that had moderate evidence
of association with R. equi pneumonia when comparing clinical and subclinical foals. A joint analysis including all study foals
revealed a 3- to 4-fold increase in odds of disease for a homozygous SNP within the associated region when comparing the
clinical group with either of the other 2 groups of foals or their combination. The region contains the transient receptor
potential cation channel, subfamily M, member 2 (TRPM2) gene, which is involved in neutrophil function. No associations
were identified in the CNV-based GWAS. Collectively, these data identify a region on chromosome 26 associated with R. equi
pneumonia in foals, providing evidence that genetic factors may indeed contribute to this important disease of foals.
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Introduction
Rhodococcus equi is an important intracellular pathogen affecting
horses, most commonly among foals in which it causes chronic,
suppurative bronchopneumonia [1], as well as extrapulmonary
disorders [2]. The cumulative incidence of pneumonia caused by
R. equi may be high at breeding farms with affected foals, and this
disease may adversely impact future racing performance [3]. At
affected farms, a varying proportion of foals will develop clinical
signs of pneumonia while the other foals remain free of the disease;
however, subclinical pneumonia can occur following either
experimental or natural infection with R. equi [4–6].
Although the factors contributing to R. equi pneumonia are
complex, recent evidence suggests that some horses may be
genetically predisposed to this condition [1,7,8]. Identifying the
genetic and biological basis of susceptibility, or perhaps resistance,
to R. equi pneumonia in foals is important, because it might lead to
the development of diagnostic and therapeutic tools to manage at-
risk foals on breeding farms and might shed light on critical host
defense mechanisms. Currently, single nucleotide polymorphism
(SNP)-based genotyping platforms are available for performing
genome-wide association studies (GWAS) in horses [9]. Use of
SNP-based genotyping platforms to identify genomic regions
associated with particular phenotypes in animals is growing at a
rapid pace [9–14]. As a result, researchers, veterinarians, and
producers increasingly rely on data from these studies to make
important production and management decisions [15,16].
Although high-density SNP arrays are powerful tools for
performing association studies, they are often inadequate for
examining structurally complex regions, particularly those en-
riched with copy number variants (CNVs) [17]. Results from the
1000 Genomes project estimate approximately 20% of CNVs are
not in linkage disequilibrium with flanking or tagging SNPs [18],
indicating that additional testing is required to accurately genotype
these variants. The identification of CNVs is further complicated
by the probe placement and design of most commercial SNP
arrays [17–19]. Comparative genomic hybridization (CGH) arrays
are optimized for genotyping CNVs. Using SNP and CGH arrays
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together may, in some instances, increase the power of a GWAS
by expanding the number of informative markers, particularly
within structurally complex regions of the genome [19].
In horses, CNVs are present in genes involved in many
biological processes and may underlie or modify many common
and disease traits [20–22]. Of the CNVs in horses identified to
date, most are enriched in genes involved in sensory perception,
signal transduction, and metabolism [22]. In other animal species,
including horses, CNVs often affect genes regulating the immune
system, particularly the MHC; they may also be causative or
modifying variants of many immune related conditions [23–30].
The genetic basis of susceptibility or resistance to R. equi
pneumonia has not been explored on a genome-wide basis. Here,
we describe independent SNP- and CNV-based GWAS to identify
genomic loci associated with R. equi pneumonia in Quarter Horse
foals. We identified a number of regions associated with R. equi
pneumonia, including a region on chromosome 26. Located
within this region is the transient receptor potential cation
channel, subfamily M, member 2 (TRPM2) gene that encodes a
protein associated with neutrophil function.
Materials and Methods
Ethics statement
All protocols for this study were reviewed and approved by the
Clinical Research Review Committee (CRRC Protocol 10–12),
College of Veterinary Medicine & Biomedical Sciences, Texas
A&M University. This study was carried out on private land
(33u379140N 100u199220W) and specific permissions for use were
granted by GPB. During the time this study was conducted,
research involving client-owned animals at Texas A&M University
was not subject to review by the Institutional Animal Care and
Use Committee. Written informed consent for participation was
obtained for all foals included in the study, and the 6666 Ranch
provided access to the foals included in this project. This study did
not involve any endangered or protected species.
Study population
The 6666 Ranch was selected as the site for this study because it
agreed to provide access to foals, had history of R. equi pneumonia
among foals with a cumulative incidence of $15% for the
preceding 3 years, and because the farm’s veterinarian/general
manager (GPB) was conducting a separate study during 2011
evaluating screening tests for R. equi pneumonia in foals, which was
directed by one of the authors (MKC). The screening test
evaluation required that treatment was not initiated for any foal on
the basis of screening test results alone, and that the veterinarians
making decisions about diagnosis and treatment of R. equi
pneumonia were not informed of the results of screening tests.
Each foal at the farm underwent bilateral thoracic ultrasono-
graphic examination at 2-week intervals, beginning at 3 weeks of
age either until 19 weeks of age or until the foal developed clinical
signs of pneumonia (as described below). Ultrasonographic
examinations were performed by a veterinarian who did not
participate in diagnosis or treatment of R. equi pneumonia. The
anatomic location (left versus right hemithorax; intercostal space;
and, dorsal, middle, or ventral region) and maximal diameter of
any areas of pulmonary abscesses or consolidation were recorded.
In addition, the total number of lesions was counted.
All foals [N= 248] born at the farm during 2011 were eligible to
be included in the study. All foals were monitored daily by farm
personnel for clinical signs of pneumonia until 20 weeks of age.
Clinical signs suggestive of pneumonia included fever, lethargy,
signs of depressed attitude, cough, nasal discharge, polysynovitis,
tachypnea, increased respiratory effort, respiratory distress, and
detection of a tracheal rattle or pulmonary crackles or wheezes via
thoracic auscultation. For each foal that developed clinical signs of
pneumonia, thoracic ultrasonography and collection of a trans-
endoscopic tracheobronchial aspirate (TBA) sample with a
commercially available triple-guarded catheter (Triple stage
tracheal wash catheter, MILA International Inc., Erlanger, KY)
were performed. Between uses, the endoscope was disinfected with
a 3.4% glutaraldehyde solution (CIDEX-PLUS, Advanced Ster-
ilization Products, Irvine, CA) following a standard protocol used
in our laboratory and known to be microbicidal against R. equi.
Each sample of TBA fluid was submitted for microbiologic culture
and cytologic evaluation to the Texas Veterinary Medical
Diagnostic Laboratory in College Station, Texas.
Foals with R. equi pneumonia (clinical group; N= 43 [17%])
were defined as those having signs of pneumonia at 3 to 20 weeks
of age, ultrasonographic evidence of peripheral pulmonary
consolidation or abscesses at the time of examination for clinical
signs of pneumonia, and R. equi detected in TBA fluid via
microbiologic culture, and cytological evidence of gram-positive
intracellular coccobacilli in the TBA sample. Subclinical foals
(N= 156 [63%]) were defined as those having ultrasonographic
evidence of peripheral pulmonary consolidation or abscesses, but
lacking clinical signs of pneumonia [31]. Unaffected foals (N= 49
[20%]) were classified as having no clinical signs of pneumonia
and no ultrasonographic evidence of pulmonary consolidation or
abscessation. From each of the 3 groups of foals (i.e., clinical,
subclinical, and unaffected), 24 foals were selected randomly for
the SNP- and CNV-based genome-wide association studies. The
rationale for including 24 foals was based on funding available to
conduct the study (rather than an a priori sample size calculation).
DNA samples and isolation
A blood sample (4 mL) was collected by jugular venipuncture
into a tube containing acid citrate dextrose (ACD) as an
anticoagulant from the first (i.e., age 3 weeks) blood sample
obtained from each foal. Genomic DNA was isolated using a
standard phenol-chloroform isoamyl extraction protocol from
these blood samples from each foal [22].
SNP genotyping and data analysis
The SNP genotyping was performed at Gene Seek (Neogen,
Lincoln, NE) using the EquineSNP70 BeadChip Array (Illumina,
San Diego, CA). The resulting SNP genotypes were analyzed
using the PLINK analysis package [32]. Genotypes were
determined for each animal and then filtered (i.e., excluded) on
the basis of missingness per individual (.10%), missingness per
SNP (.10%) minor allele frequency (,5%), and absence of
Hardy-Weinberg equilibrium (P,0.001), as described by Raud-
sepp et al. [12]. A standard chi-square association test (Max(T)
permutations [N= 10,000]) based on a binary outcome of disease
status using a case-control design was performed using PLINK
[12,33]. Genotype ped files were loaded into PLINK and foals
were assigned a phenotypic status of either affected or unaffected
(case/control). A P value of P,161025 was considered evidence
of association [34]. Population stratification was determined using
plots of the observed versus the expected -log10 P values of
Cochran-Armitage trend tests and by determining the genomic
inflation factor, l, using the R package GenABEL [35]. Using the R
package pedigreemm [36], mixed-effects logistic regression with
sire modeled as a random effect was used for the association test in
comparisons showing evidence of population stratification; SNPs
with any genotype represented fewer than 10 times were removed
from analysis to permit model convergence [35–37]. All SNP
R equi Pneumonia SNP and CNV GWAS
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array data have been deposited in NCBI’s Gene Expression
Omnibus (GEO) [38] and are accessible through GEO Series
accession number GSE57510 (http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc =GSE57510).
Joint analysis
Genotyping for the joint analysis was performed using a tetra-
primer AMRS PCR genotyping reaction [39] of an individual
SNP (SNP ID:UKUL3936) present on the EquineSNP70 array
and located within the TRPM2 gene (Forward outer: 59-
ATCAGCCAGACACTCCAGGCATGACAT-39; Forward in-
ner: 59-CATCCTCCTCAGCCACCTGCATCTTTT-39; Re-
verse outer: 59-ATCTCAGAAGGAGCTGCCATGCCTACC-
39; and, Reverse inner: 59-GTATCTTCAGGACCACCCTCCT-
GACGC-39). The primers were designed using Primer3 software
[40] and synthesized by Sigma-Aldrich (St. Louis, MO). The PCR
reactions were performed under these conditions: 9.8 ml mili-Q
H20, 4 ml Taq FlexiBuffer (Promega, Madison, WI), 2 ml MgCl2,
0.4 ml dNTPs, 0.1 ml Taq (Promega), 1 ml forward and reverse
inner primer, 0.1 ml forward and reverse outer primer, and 1.5 ml
of DNA at 50 mg/ml. Cycling conditions were as follows: 94uC for
2 m; 35 cycles at 94uC for 1 m; 65.8uC for 1 m; 72uC for 1 m;
and, a final extension at 72uC for 2 m. PCR amplicons were
resolved on a 2% agarose gel.
Genotype data from the joint analysis were analyzed using
logistic regression on the basis of the binary outcome of disease
(pneumonia versus each of the respective comparison groups [i.e.,
clinical foals, subclinical foals, and unaffected foals]). The
association of disease with genotype for the SNP was expressed
as the odds ratio (OR), estimated from logistic regression
modeling; 95% confidence intervals were estimated using maxi-
mum likelihood methods. Models were fit for comparisons of
clinical versus subclinical foals, clinical versus the combination of
subclinical and unaffected foals, and clinical versus unaffected
foals. Models were fit using S-PLUS statistical software (Version
8.2, TIBCO, Inc., Seattle, WA). A significance level of P,0.05
was used for the analyses.
CNV detection and analyses
Copy number variants were identified using a previously
reported equine exome array for comparative genomic hybrid-
ization (CGH)[41]. An individual Quarter Horse mare was used as
the reference sample for each CGH experiment [22]. Array CGH
was performed using methods described by Doan et al. [41].
Briefly, genomic DNA was sonicated and then labeled with the
Cy5 (experimental) and Cy3 (reference) AlexaFluor dyes using the
BioPrime Plus labeling kit (Invitrogen, Carlsbad, CA). Two mg of
reference and experimental DNA were hybridized onto the arrays
(Agilent Technologies, Santa Clara, CA). The arrays were scanned
using an Agilent DNA Microarray Scanner (2-mm settings and
0.05 XDR). Fluorescent intensity values were calculated using
Agilent’s Feature Extraction 10.5 software (Agilent). Copy number
variants, including their corresponding log2 ratios, were identified
using Agilent’s Genomics Workbench 7.
Copy number variants were called using the ADM-2 algorithm
and the following filters: minimum probe span $3 and average
log2 ratio $0.5, removal of probes with $3 standard deviations
above or below the mean log2 fluorescent intensity.
Logistic regression modeling was used to perform 2 separate
CNV-based GWAS. The first approach modeled the association of
the binary outcome of 2 groups (e.g., clinical versus subclinical)
with the log2 ratio of intensity values (a continuous variable) for
each CNV. The second approach modeled the association of the
binary outcome of 2 groups with the presence or absence of a
CNV (a binary categorical variable) within a CNV region. For the
first approach, CNV regions (CNVRs) were determined for the
foals examined. The CNVRs were then filtered to include only
CNVs identified in at least 3 foals. The log2 ratios of probes within
each CNVR were then averaged to calculate a single log2 (CNVR-
log2 ratio) for each CNVR for each foal. The CNVR-log2 values
were used in a logistic regression model to identify associated
CNVs among the pairwise comparisons of the 3 groups (case-
control design described above). For the second approach, a
logistic regression model involving the binary outcome of presence
(or absence) of a CNV within each CNVR was used to identify
associated CNVs among the pairwise comparisons of the 3 groups.
For both approaches, the generated P values from linear modeling
or regression analyses were corrected for multiple comparisons
using the method outlined by Hochberg et al. [42]. Statistical
analyses were performed using R (Version 3.0.1; R Statistical
Project). All CNV data have been deposited in NCBI’s Gene
Expression Omnibus (GEO) [38] and are accessible through GEO
Series accession number GSE57510 (http://www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?acc =GSE57510).
Results
SNP-based GWAS
Three case-control GWAS were performed among the 24
randomly selected foals representing each group (clinical group,
subclinical group, and unaffected group; Figure 1). The number
of SNPs excluded on the basis of missingness per individual,
missingness per SNP, and minor allele frequency were 0, 1,292,
and 11,157, respectively (12,449 total SNPs). For comparisons 1,
2, and 3 (Figure 1), the number of SNPs excluded on the basis of
Hardy-Weinberg equilibrium were 0, 83, and 54, respectively.
After filtering, the total genotyping rate of the foals was estimated
at 99.4%. Comparison 1 (clinical [N=24] vs. subclinical +
unaffected [N= 48]; l=1.16) identified 7 regions showing
evidence of moderate association with clinical pneumonia (P,
161025) (Figure 2A and Table 1). Comparison 2 (clinical
[N= 24] vs. subclinical [N= 24]; l=1.00 [Figure S1A]) identi-
fied 10 regions with moderate association (Figure 2B and
Table 1). The region associated with clinical pneumonia had a
(point-wise) value of EMP1 #0.0002. Comparison 3 (clinical
[N= 24] vs. unaffected [N= 24]; l=1.44 [Figure S1B]) identi-
fied 2 regions with moderate association (Figure 2C and
Table 1). Results from each GWAS comparison are provided
in Table S1.
The l value of comparison 3 (1.44) suggested evidence of
confounding population structure from 1 of the groups, thus
mixed-effects modeling with sire as the random effect term was
used as an additional association test. There were 23,318 SNPs
filtered due to failure to converge in mixed modeling, leaving
40,843 SNPs for evaluation in comparison 3. The logistic mixed-
effects modeling reduced the l from 1.44 to 1.10 (Figure S1D),
and inspection of the observed versus expected P value plot
indicated that none of the smallest P values [highest –log10 P
values] observed were greater than expected (Figure 2D and
Table S2). The mixed-effects model analysis identified 1 region
with modest evidence of association (BIEC2_284540;
chr15:7,394,044; P= 9.06105). The l values of each comparison
suggested the population structure was attributable to foals in the
unaffected group because the magnitude of l was greatest for the
comparison of clinical versus unaffected groups (i.e., strongest
evidence of population stratification), was 1.00 for clinical versus
subclinical groups (i.e., absence of population stratification), and
1.14 when the clinical group was compared with the combination
R equi Pneumonia SNP and CNV GWAS
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of healthy and subclinical (indicating the healthy group contrib-
uted to evidence of population stratification for this comparison).
A region on chromosome 26 (chr26:39,640,172–39,867,963)
showed evidence of association with clinical pneumonia (Com-
parisons 1 and 2), with the strongest evidence of association in
comparison 2. Three of the 4 SNPs identified in this region were
BIEC2_732054, BIEC2_696979, and BIEC2_696992, with the
first lying in a keratin-associated protein (KRTAP) gene and the
remaining 2 SNPs lying in non-genic locations. The region also
contained a potential candidate gene (TRPM2) based on biological
function [43] identified by the SNP marker, UKUL3936
(P = 9.9361026; OR=12.7), which was also located within exon
22 of the TRPM2 gene. On the basis of this finding, a joint analysis
was performed to include results of PCR-based genotyping of the
UKUL3936 SNP for the samples from the larger remaining
population of foals not included in the GWAS study (i.e., clinical
[N=19], subclinical, [N=132], and unaffected [N= 25]). Prior to
performing the joint analysis, 10 of 72 foals previously genotyped
on the SNP array were used to validate the genotyping reaction
used for the joint analysis; results of SNP array and PCR
genotyping agreed for all 10 foals. The joint analysis comparing
clinical versus subclinical foals (comparison 2) revealed that foals
from the clinical group were approximately 4-fold less likely to
have either an AB (1/(0.23) = 4.3; P= 0.0017) or BB genotype (1/
(0.28) = 3.6, P= 0.0574), consistent with a dominant model,
possibly with partial penetrance (Table 2). Considering just the
AA genotype relative to the other genotypes, the odds of disease
were approximately 3.7-fold greater for foals with the AA
genotype (Table 2; P= 0.0006). Using an additive model, there
was a significant (P = 0.0014) association of the A allele in
comparisons between the clinical and other groups, with an
estimated odds of a clinical classification being increased nearly 3-
fold for each copy of the A allele. Examination of the genotype
data, however, suggested an additive model was unlikely: the ORs
for the AB and BB types relative to the AA genotype were similar.
The AA genotype of the TRPM2 gene also was significantly
associated with increased odds of R. equi pneumonia when
considering the results of comparisons of the clinical foals versus
all foals (comparison 1; Table S2) and for clinical foals versus
healthy foals (comparison 3; Table S3), irrespective of the genetic
model.
CNV-based GWAS
Next, array aCGH was performed to genotype CNVs in the 72
foals examined in the SNP-based GWAS. Two reactions failed to
meet the minimum quality scores for CNV detection, so they were
excluded from the study (foals 153 and 278). Collectively, 6,727
CNVs were identified among the 70 foals (Table 3 and Table
S3). Merging shared CNVs yielded 2,350 CNV regions (CNVR)
that were present at 3,492 Ensembl annotated genes (3,442
protein-coding and 50 RNA-coding). The lengths of CNVs ranged
from 197 base-pairs (bp) to 7,229.5 kilo-bp (kb), with a mean
length of 97.7 kb, median length of 4.4 kb, and mode length of
960 bp.
The association between disease status (the outcome variable)
and individual CNVs (dependent variable) was assessed using
logistic regression analysis. Because CNV genotypes reflect
differences in DNA content between 2 individuals and are
expressed as normalized log2 ratios representative of varying
degrees of copy number gains and losses, separate logistic
regression modeling was performed using CNVs as the dependent
variable as either 1) continuous variables representing average log2
ratios of CNVRs or 2) a binary variable representing the presence
or absence of a given CNV (see Materials and Methods section).
Comparisons among groups of foals were made in the CNV-based
GWAS as described above (Figure 1). Correction for multiple
comparisons revealed no significant (P,0.05) associations of
disease with CNVs when considered as continuous log2 ratios
(Table 4) or as the binary outcome for presence or absence of a
CNV. No association with clinical status grouping was detected on
the basis of the total number of CNVs for individuals (Table 3).
Discussion
Rhoddococcus equi is an important cause of disease and death in
young foals [44]. Multiple factors such as age, environmental
conditions including level of exposure to virulent organisms, and
genetic background appear to play a role in the occurrence of this
Figure 1. Schematic diagram representing the distribution of the total population into the 3 subgroups (R. equi pneumonia foals
[clinical], subclinical foals, and unaffected foals), and by genome-wide association studies versus PCR genotyping for TRPM2 SNP.
The 3 comparisons among groups are also summarized.
doi:10.1371/journal.pone.0098710.g001
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Figure 2. Manhattan plots of standard chi-squared significance values for the 3 genome-wide association studies.Manhattan plots for
(A) comparison 1, (B) comparison 2, and (C) comparison 3; (D) Mixed effects-model analysis of comparison 3.
doi:10.1371/journal.pone.0098710.g002
R equi Pneumonia SNP and CNV GWAS
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complex disease [45–47]. The purpose of this study was to better
characterize the genetic basis of susceptibility to R. equi pneumo-
nia. One special feature of this study was the phenotypic
characterization of foals into those that remained unaffected (i.e.,
free of both clinical signs and ultrasonographic evidence of disease)
through weaning, those that had subclinical pneumonia (i.e.,
absence of clinical signs but ultrasonographic evidence of
pulmonary lesions), and those that developed R. equi pneumonia.
At most farms where screening is performed, foals with evidence of
subclinical pneumonia receive treatment or other interventions
that precludes one from differentiating foals that would have
progressed to clinical disease from those that would have remained
subclinical. At the farm described in this report, however, foals
with subclinical pneumonia were not treated or otherwise
managed differently than unaffected foals providing us with the
Table 1. Moderately associated SNPs for each genome-wide association study.
Comparison 1
SNP ID Chromosomal location P Value Odds Ratio
BIEC2_921509 5:79290169 2.21E-05 0.2
BIEC2_1137861 9:19578673 4.42E-05 9.556
BIEC2_976727 5:91479639 5.10E-05 0.09677
BIEC2_650473 24:41033593 5.16E-05 0.04274
BIEC2_732054 26:39777632 6.78E-05 12.05
BIEC2_696979 26:39861109 6.78E-05 12.05
BIEC2_696992 26:39867963 6.78E-05 12.05
BIEC2_492054 2:80197359 7.73E-05 0.2036
BIEC2_240596 13:31572932 8.94E-05 0.156
BIEC2_825623 30:20687203 9.79E-05 0.2369
BIEC2_867975 30:20690855 9.79E-05 0.2369
Comparison 2
SNP ID Chromosomal location P Value Odds Ratio
BIEC2_732054 26:39777632 5.54E-06 17.89
UKUL3936 26:39640172 9.93E-06 12.69
BIEC2_696979 26:39861109 1.24E-05 16.43
BIEC2_696992 26:39867963 1.24E-05 16.43
BIEC2_16162 1:35593058 5.80E-05 13.8
Comparison 3
SNP ID Chromosomal location P Value Odds Ratio
BIEC2_927543 5:88617368 1.63E-05 0.1486
BIEC2_311792 15:54419913 1.75E-05 0.1515
BIEC2_284540 15:7394044 2.21E-05 0.08571
BIEC2_240596 13:31572932 2.41E-05 0.1163
BIEC2_858227 30:6939831 2.99E-05 0.1512
BIEC2_1078504 9:19582539 3.37E-05 0.1314
BIEC2_310113 15:51485703 3.57E-05 0.1074
BIEC2_310214 15:51596762 3.57E-05 0.1074
BIEC2_324522 15:51634407 3.57E-05 0.1074
BIEC2_921509 5:79290169 4.19E-05 0.1667
BIEC2_784299 3:59782881 4.45E-05 0.1445
BIEC2_239002 14:3055273 4.46E-05 0.1696
BIEC2_976312 5:90703095 4.80E-05 0.09333
BIEC2_928796 5:90706671 4.80E-05 0.09333
BIEC2-815626 30:5321760 7.70E-05 0.1169
BIEC2_784331 3:59874438 7.87E-05 5.8
BIEC2_784332 3:59874495 7.87E-05 5.8
BIEC2_869756 4:72076243 7.87E-05 5.8
BIEC2_435811 19:33380654 8.85E-05 0.1784
BIEC2_1137861 9:19578673 9.20E-05 10.09
doi:10.1371/journal.pone.0098710.t001
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exceptional opportunity to conduct GWAS’s with 3 clinically
important phenotypes.
A SNP-based GWAS revealed a region on chromosome 26
(chr26:39640172–39867963) that was positively associated with
disease. This region contains the TRPM2 gene, which is associated
with neutrophil function. Although, TRPM2 is an ideal candidate
based on its known biological function, an adjacent SNP located
within the KRTAP gene was more strongly associated than the
SNP located with TRPM2. Further, investigation of this region
(e.g., fine-mapping of the region) is needed before any conclusion
can be made regarding the role of TRPM2 in R. equi pneumonia.
Nevertheless, TRPM2 is of interest because it has been demon-
strated in mice to play a role in neutrophil-mediated tissue damage
[43]. Neutrophils have been shown to play an important role in
the outcome of R. equi infection. Neutrophil-depleted mice had
significantly heavier tissue burdens of R. equi following experimen-
tal infection than non-depleted mice, documenting a protective
role for neutrophils [48]. The neutrophil concentrations at 2 and 4
weeks of age were significantly lower among foals that subse-
quently developed R. equi pneumonia than among age-matched
foals that did not develop pneumonia [49]. Similar protective roles
for neutrophils have been documented for other intracellular
pulmonary pathogens [48,50,51]. Moreover, R. equi has an age-
dependent distribution (i.e., foals are usually affected and adults
are generally resistant to infection), and age-related differences in
neutrophil responses to R. equi have been documented [52–54].
Although neutrophils play a role in protecting against R. equi
infection, they also contribute to lung parenchymal damage of this
pyogranulomatous disease [44,55]. In a mouse model of ulcerative
colitis, the over-abundance of neutrophil invasion into tissue
mediated by TRPM2 expression, led to increased colonocyte death
[43]. Thus, variation in TRPM2 expression could influence the
extent to which neutrophil-induced pulmonary damage occurs
following infection with R. equi, and this variation could be a
crucial determinant of the clinical outcome of infection with R. equi
and the progression from subclinical to clinical pneumonia. If the
TRPM2 allele implicated in our study were associated with
increased TRPM2 expression, it might consequently be associated
with greater likelihood of pneumonia development as a result of
greater neutrophil invasion. The functional effects of this TRPM2
genotype are unknown, however. Interestingly, expression of a
splice variant of TRPM2 was demonstrated to inhibit death of
several cultured cell lines [56]. Further evaluation of the functional
differences in neutrophilic responses among TRPM2 genotypes is
warranted.
A CNV-based GWAS was conducted and revealed no
significant association with disease status. Despite the negative
findings, these results are of interest with regard to better
characterizing genetic variation in horses and using CNVs for
GWAS with disease outcomes. A search of PubMed reveals no
other attempt to perform a CNV GWAS via aCGH in horses and
to the authors’ knowledge no others have been done. Valuable
information was gained in terms of the analysis of CNV data
generated from a GWAS using aCGH. The identification of
CNVs is based on log2 ratios of intensity signals that are generated
between the reference and sample DNA. The results may be
interpreted either as presence or absence of a CNV, based on a
threshold intensity value [41], or the actual intensity values
themselves. As observed in this study, these 2 outcomes for CNV-
calling yielded differing results. We propose that utilizing average
log2 ratios across CNV regions is superior because classification of
CNVRs by presence or absence does not further characterize a
Table 2. Joint analysis of TRPM2 SNP UKUL3936.
Genotype
Standard Model Clinical foals Subclinical foals P value Odds Ratio (95% CI)
AA 72% (31/43) 41% (64/156) NA 1 (NA)
AB 23% (10/43) 47% (74/156) 0.0017 0.28 (0.13 to 0.61)
BB 5% (2/43) 12% (18/156) 0.0574 0.23 (0.05 to 1.04)
Dominant Model
Not AA 28% (12/43) 59% (92/156) NA 1 (NA)
AA 72% (31/43) 41% (64/156) 0.0006 3.71 (1.78 to 7.76)
Additive Model
f(A)* 2(0 to 2) 1(0 to 2) 0.0014 2.83 (1.51 to 5.31)
(72/86) 84% (202/312) 65%
*Median (range) reported for frequency of allele A, along with the proportion of A alleles among all alleles represented for each group. Joint analysis includes genotypes
derived from SNP array and PCR genotyping.
doi:10.1371/journal.pone.0098710.t002
Table 3. CNVs identified in the each clinical group.
Clinical foals Subclinical foals Unaffected foals P Value
Total CNVs 84 (29 to 592; 2,654) 57 (29 to 338; 1,823) 77 (28 to 254; 2,250) 0.262
Gains 25 (8 to 395; 1,229) 24 (9 to 187; 770) 30 (10 to 152; 957) 0.334
Losses 41 (15 to 197; 1,425) 36 (16 to 151; 1,053) 40 (16 to 139; 1,293) 0.574
CNVs: median (range; sum); Kruskal-Wallis test.
doi:10.1371/journal.pone.0098710.t003
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CNV, whereas analysis of the log2 ratios allows for the
identification of whether the CNV involved gains or losses, and
for description of the magnitude of the gain or loss.
We failed to identify significant association with candidate genes
previously associated with R. equi pneumonia in other breeds of
foals [1,7,8]. This may have been attributable to differences
among populations of foals studied (e.g, breeds) or study
methodology (e.g, case definitions, methods for detecting poly-
morphisms, etc.). Nevertheless, a commonality among these
studies can be found in their identification of genes pertaining to
host defenses against infectious pathogens, such as iron transport
and innate immune responses. Conceivably, these apparently
discrepant findings may converge on critical biological pathways
or processes that influence susceptibility to infection with R. equi
(and other intracellular pathogens).
This study had a number of limitations. First, it was likely
underpowered for both the SNP- and CNV-based GWAS portions
of the study: we only had the opportunity to find SNPs or CNVs
with large effects. This lack of power is probably why we did not
identify highly significant associations in the SNP-based GWAS
for 2 of our 3 comparisons (Figure 1), and only moderate
significance for the allele identified in comparison 2. Although
sample sizes may be calculated for human studies, methods for
incorporating crucial determinants of sample size such as the
impact of the relatively longer length of linkage disequilibrium in
horses relative to humans remain to be defined. Moreover, the cost
of GWAS studies and the limited funding available for equine
research can be restrictive. It is worth noting that our SNP-based
GWAS did provide sufficient power to identify a SNP associated
with R. equi that was subsequently substantiated by findings of the
joint analysis using PCR testing of additional foals from this
population for all 3 comparisons. Nevertheless, larger scale studies
are indicated. For example, 1 locus on chromosome 15 (in the
promoter region of a chemokine) was weakly associated in both the
mixed-effects modeling and standard GWAS analyses for com-
parison 3: this finding could be simply attributable to chance but
also could represent an underpowered association that merits
further investigation.
A limitation of this study is that it was restricted to foals of a
single breed at a single farm. Further studies are indicated to
substantiate whether the observed association holds among other
Quarter Horse foals at other farms, and among foals of other
breeds. Another limitation was that although the mixed modeling
for comparison 3 yielded a marked reduction in the estimated
value of l (from 1.44 to 1.10), the mixed modeling value of l
suggested residual confounding from population structure. Graph-
ical analysis of the results of mixed modeling, however, suggested
this was not the case: the plot of observed versus expected P values
indicated that fewer than expected small P values were identified
and more than expected large P values were observed following
mixed-effects modeling, and Manhattan plots of the standard and
mixed-effects model GWAS for comparison 3 revealed a shift to
larger P values following mixed-effects modeling (Figure S1).
Moreover, the linear regression-based estimate of l had a poor fit
because the data were non-linear in the range of the high P values
(data not shown). We interpreted these results to indicate that the
mixed-effects modeling had largely corrected for population
stratification attributable to sire, and that the study was
underpowered. As noted, a limitation of this study is that we lack
fine-mapping of the region to determine whether the TRPM2
allele is a causal variant or simply in linkage disequilibrium with
another gene or genes that contribute to susceptibility to R. equi.
Finally, it must be noted that although the estimated OR for the
TRMP2 SNP was relatively large, it is not of sufficient magnitude
to be clinically useful for screening purposes.
Despite the aforementioned limitations, this study has identified
a region on chromosome 26 that was associated with R. equi
pneumonia in foals, and the largest scale GWAS in foals reported
to date. Furthermore, it extends current knowledge of equine
CNVs and analysis of data from GWAS using aCGH in horses.
Conclusions
In conclusion, the results of this study identify a locus and gene
potentially involved in the development of R. equi pneumonia in
foals. Future studies are warranted to substantiate the association
of TRPM2 gene (and related pathways) with R. equi pneumonia
and to provide fine-mapping of the region on chromosome 26
implicated in this GWAS.
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269 chr2:6304157-6378969 458 chr3:36530104-36530453
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